Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.99 million), the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB was founded in 1991 and based in Stockholm, Sweden.
Frequently asked questions
What sector does Linc AB (LINC) operate in?
Linc AB belongs to the Industrials sector and operates in the Asset Management industry.
What is Linc AB (LINC) current stock price?
As of the latest data, Linc AB stock price is SEK 74.10, with a previous close of SEK 74.20. Linc AB lost -SEK 0.10 in the last trading session, representing a -0.13% loss.
What is Linc AB (LINC) current market capitalization?
Linc AB market cap is approximately 4.29 billion.
What is Linc AB (LINC) Earnings Per Share (EPS)?
The trailing EPS is SEK 5.60.
What is Linc AB (LINC) Price-to-Earnings (P/E) ratio?
Linc AB current P/E ratio is 13.23.
What is Linc AB (LINC) EBITDA?
Linc AB EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 243.63 million.
Does Linc AB (LINC) pay dividends?
No. Linc AB does not pay a dividend.
What is Linc AB (LINC) beta (volatility) score?
Linc AB has a beta of 0.688, indicating lower volatility than the overall market.
